title: Beta-endorphin fragments (DT gamma E and DE gamma E) reduce opiate withdrawal in guinea pig ileum.
abstract: The effect exerted by two beta-endorphin fragments (DTgammaE and DEgammaE) was investigated on the acute opioid dependence induced by mu, kappa and delta receptor agonists in vitro. After a 4-min in vitro exposure to morphine (less selective mu agonist), DAGO (highly selective mu agonist), U50-488H (highly selective kappa agonist) and beta-endorphin (selective mu-delta agonist), a strong contracture of guinea pig isolated ileum was observed after the addition of naloxone. This effect was also observed when rabbit isolated jejunum was pretreated with deltorphin (highly selective delta agonist). DTgammaE or DEgammaE injection treatment before or after morphine, DAGO, U50-488H, beta-endorphin or deltorphin were able to both prevent and reverse the naloxone-induced contracture after exposure to the opioid agonists in a concentration-dependent fashion. Our results indicate that both DTgammaE or DEgammaE are able to reduce significantly opioid dependence in vitro, suggesting an important functional interaction between beta-endorphin fragments and opioid dependence induced by mu, kappa and delta receptors.
authors.affiliation: Dipartimento di Scienze Farmaceutiche, Università di Salerno, Italy. annacap@unisa.it
authors.forename: Anna
authors.initials: A
authors.lastname: Capasso
authors.forename: Alberto
authors.initials: A
authors.lastname: Loizzo
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects; D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004723:Endorphins / Q000494:pharmacology* / Q000627:therapeutic use*; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects* / Q000502:physiology; D008297:Male; D009020:Morphine / Q000009:adverse effects; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D009293:Opioid-Related Disorders / Q000188:drug therapy; D010446:Peptide Fragments / Q000494:pharmacology* / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D001615:beta-Endorphin / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D000701:Analgesics, Opioid; D000928:Antidepressive Agents; D004723:Endorphins; D010446:Peptide Fragments; D001615:beta-Endorphin; C018903:gamma-endorphin, des-Tyr(1)-; C033558:des-enkephalin-gamma-endorphin; D009020:Morphine